Ríos CJL, Sánchez SJJ, Barrios SP, Guerrero SV

Language: Spanish
References: 37
Page: 109-116
PDF size: 130.61 Kb.

ABSTRACT

Type 2 diabetes mellitus represents a public health concern in Mexico. This illness has an impact as much physical as emotional; throughout the chronicity process, the process deteriorates quality of life in persons suffering from it. For this reason, the purpose of the present investigation was to determine the impact of deterioration of quality of life in a sample of patients with type 2 diabetes mellitus (DM2). We carried out an expo-facto, transverse-type study in which we attempted to identify and typify possible functional peculiar-ities. The patients participating in the study were 100 persons who came for out-patient consul-tation at a clinical hospital of the IMSS in the capital city of San Luis Potosí in Mexico who were diagnosed with DM-2 by their own physicians. Deterioration in quality of life was measured with Scale of Quality of Life Related with Health (ESCAVIRS) in its validated version and stand-ardized Spanish. The dependent variable to consider was evaluation of index of deterioration of quality of life estimated by ESCAVIRS scale. The independent variable was understood as evolution time of chronic-degenerative condition of DM2 of selected patients, as well as certain sociodemographic aspects. Results revealed that 43 % of the studied sample dealt with some degree of deterioration in quality of life in evaluated areas included in the scale. Areas of interaction stand out with the health team, sexual dysfunction, and emotional and physical aspects, among others. Patients with › 5 years of evolution of DM2, low educational level, and › 50 years of age were at risk for deterioration. We conclude that degree of deterioration of quality of life in this type of patient with DM2 is progressive and is associated with the degenerative evolution of the illness.

REFERENCES

1. 1. Rodríguez OG, Rojas RM. La psicología de la salud en América Latina. México: Miguel Ángel Porrúa; 1998. p. 13-32.

2. 2. Sánchez-Sosa JJ. Desde la prevención primaria hasta ayudar a bien morir: la interfaz intervención-investigación en psicología de la salud. En: Rodríguez G, Rojas M, compiladores. La psicología de la salud en América Latina. México: Miguel Ángel Porrúa; 1998. p. 33-44.

3. 3. Kuopio AM, et al. The quality of life in Parkinson’s disease. Mov Disord 2000;15(2):216-223.

4. 4. Korczyn AD, Davidson M. Quality of life. Eur J Gynaecol Oncol 1999;17(1):5-6.

5. 5. Heinrich RL, et al. Living with cancer: the cancer inventory of problem situations. J Clin Psychol 1984; 40:972-980.

6. 6. Fawzy FI, Fauwzy NW. Group therapy in the cancer setting. Psychother Res 1998;45(3):191-200.

7. 7. Lara MC, Ponce-de-León S, De-la-Fuente JR. Con-ceptualización y medición de la calidad de vida en pa-cientes con cáncer. Rev Invest Clin 1995;47(4):315-327.

8. 8. González-Villapando C. Prevalencia de diabetes e insuficiencia a la glucosa en una población urbana de nivel socioeconómico bajo. Rev Invest Clin 1992; 44:321-328.

9. 9. Quibrera IR. Prevalencia de diabetes, intolerancia a la glucosa y factores de riesgo en función del nivel socioeconómico. Rev Invest Clin 1994;46:25-36.

10. Vásquez RM. Prevalencia de diabetes mellitus no insulinodependiente y factores de riesgo asociados en una población de México, D.F. Gac Med Mex 1993;129(3):191-199.

11. Secretaría de Salud. Encuesta nacional de enfer-medades crónicas. México: SSA; 2002.

12. Guerrero RJ, Rodríguez MM. Complicaciones rela-cionadas con la mortalidad por la diabetes mellitus: un análisis de mortalidad por causa múltiple. Med Interna Mex 1997;13(6):263-267.

13. Cairney J, Wade TJ. Correlates of body weight in the 1994 National Population Health Survey. Inter J Metabolic Dis 1998;22(6):584-591.

14. Haynes LC. Barriers to regimen adherence among persons with no insulin dependent diabetes. J Behav Med 1996;9:1.

15. Polly KR. The relationship between health beliefs, adherence, and metabol control of diabetes. Public Health Rep 1994.

16. De-los-Ríos CL, Guerrero-Sustaita V. Depression in the patients with DM2 and diabetic nephropathy. Desarrollo Científico de Enfermería 2003;5:136-140.

17. Garay SM, et al. Perceived psychosocial stress in diabetes mellitus type 2. Rev Invest Clin 2000;50(4): 287-291.

18. Rush LL. Affective rations to multiple social stigmas. J Soc Psychol 1998;138(4):421-430.

19. Levil L, Anderson L. Psychosocial stress: population, environment and quality of life. New York: SP Books Division of Spectrum Publications, Inc./UNAM. México; 1975 (para practicantes de trabajo social).

20. Andersen RM, Davidson PL, Ganz PA. Symbiotic relationships of quality of life, health services and others health research. Qual Life Res 1994;3:365-371.

21. Fount A. Valoración de la calidad de vida en pa-cientes con cáncer, Tesis doctoral, Universidad Autónoma de Barcelona, España, 1998.

22. Ringdal GI, Ringdal K, et al. Quality of life of cancer patients with different prognoses. Qual Life Res 1994;3:143-154.

23. Bowling A. Measuring health: a review of quality of life measurement scales. En: Grau JA, editor. Calidad de vida: problemas en su investigación. Cuba; 1992.

24. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life: a conceptual model of patients outcomes. JAMA 1995;273:59-65.

25. González-Puente JA, Sánchez-Sosa JJ. Systematic assessment of quality of life in HIV-positive patients at three clinical stages of the infection. Int J Clin Health Psychol 2001;1(3):519-528.

26. Baum N. Evaluation and treatment of organic impotent in the male diabetes mellitus. Diabetes Educator 1998;14:123-129.

27. Dunning P. Sexuality and woman with diabetes mellitus. Patient Educ Counsel 1993;21(1-2):5-14.

28. Guirquis W. Impotent in diabetes: facts and fictions. Diabet Med 1992;9:286-296.

29. Morrison H. Diabetic impotence. Nurs Times 1998; 84:35-37.

30. Ragonesi PD, et al. The impact of diabetes mellitus on quality of life in elderly patients. Arch Gerentol Geriatr 1998;Suppl 6:417-422.

31. Whitty P, Steen N, et al. A new self-completion outcome measure for diabetes: Is it responsive to change? Qual Life Res 1997;6(5):407-413.

32. Schiel R, Muller UA. Intensive or conventional therapy in type 2 diabetic patients? A population-based study on metabolic control and quality of life. Exp Clin Endocrinol Diabetes 1999;107(8):506-511.

33. De Graw WJ, et al. The impact of type 2 diabetes mellitus on daily functioning. Fam Pract 1999;16(2):133-139.

34. Shen W, et al. Development and validation of the diabetes quality of life clinical trial questionnaire. Med Care 1999;37(4):45-66.

35. Bradley C, et al. The development of an indivi-dualized questionnaire measure of perceived impact of diabetes mellitus on quality of life: the ADDQoL. Qual Life Res 1999;8(1-2):79-91.

36. Hanninen J, et al. Quality of life in NIDDM patients with the SF-20 questionnaire. Diabetes Res Clin Pract 1998;42(1):17-27.

37. Kohen D. The role of anxiety and depression in qua-lity of life and symptom reporting in people with dia-betes mellitus. Qual Life Res 1998;7(3): 197-204.